Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Genedrive to premiere Hepatitis C test at Asia-Pacific medical exhibition

The AIM-listed diagnostics company said the kit would make its debut at the MEDLAB Asia Pacific Exhibition & Congress in Singapore

Genedrive PLC (LON:GDR) has said it will premiere its HCV ID Kit in the Asia-Pacific (APAC) region on 2-4 April 2018.

The AIM-listed diagnostics company said the kit would make its debut at the MEDLAB Asia Pacific Exhibition & Congress in Singapore.

READ: Genedrive extends global coverage with new distribution agreement in India

The conference, the firm said, is a significant and highly attended event in the Asia Pacific region for leading companies to showcase their technologies and innovations in the field of laboratory diagnostics. With over 4,000 delegates from around the world, the congress features products in many areas including point of need and infectious diseases.

The company’s APAC debut comes after it announced its first commercial sales of instruments and assays to Sysmex Europe GmbH to cover Europe, Middle East and Africa and Sysmex Asia Pacific Pte Ltd for the Asia Pacific region, excluding India.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK